Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 5 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.

Arterial stiffness tied to lower cardiorespiratory fitness

24 Oct 2019

Arterial stiffening compromises exercise capacity and cardiorespiratory fitness in patients with coronary artery disease (CAD) and myocardial infarction, a recent study has found.

Researchers performed a cross-sectional analysis of 96 CAD patients with myocardial infarction (mean age, 55.9±10.9 years; 81 males), in whom carotid-femoral pulse wave velocity was used for the assessment of arterial stiffness. Cardiorespiratory fitness was measured primarily through peak oxygen uptake.

Grouping participants into tertiles of arterial stiffness revealed an inverse correlation with cardiorespiratory fitness. For instance, those in the topmost tertile showed significantly lower oxygen uptake than the second and first tertiles (23.3±4.9 vs 28.3±5.5 and 31.3±6.0 mLO2·kg-1; p<0.001). The difference between the second and first tertiles was not significant (p=0.13).

Setting the arterial stiffness threshold at 10 m/s, researchers found that 30 patients (31.3 percent) went over this value and were classified as high-risk. These patients had significantly reduced peak oxygen uptake than their counterparts whose arterial stiffness did not exceed the cut-off (23.0±4.7 vs 29.8±6.2 mLO2·kg-1; p<0.001).

The above relationships remained significant even after controlling for confounders, such as age, sex, cardiovascular risk factors and medication.

However, age continued to exert a substantial effect on the link between arterial stiffness and cardiorespiratory fitness. Younger patients with low-risk arterial stiffness had significantly better cardiorespiratory fitness than their older, high-risk counterparts (p<0.05). In contrast, the difference between younger, high-risk and older, low-risk patients was null.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 5 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.